ARC connects pharmaceutical companies with health systems through structured post-discharge care coordination. It generates the prospective patient data that no claims database provides.
The gap between hospital discharge and stable outpatient care is where patients fall through. It is also where the most valuable clinical evidence in pharma goes uncollected.
Pharmacy claims reflect a missed refill 30 to 60 days after the fact. By the time Medical Affairs sees the signal, the readmission window has already opened and the patient is already lost.
Claims tell you a patient stopped therapy. They do not tell you it was because the copay hit $160 when the sample supply ran out, or because a side effect was never addressed. That distinction is worth billions in Patient Services spend.
Health systems absorb readmission penalties under HRRP without the infrastructure or funding to run proactive post-discharge outreach. The cost of inaction falls entirely on the hospital.
ARC aligns the incentives of hospitals and pharmaceutical companies around a shared infrastructure and generates evidence neither could produce alone.
Care coordinators reach patients at 30, 60, and 90 days post-discharge. Adherence status, barriers, copay reach, and side effect type are captured live, not reconstructed from claims months later.
Pharmaceutical partners fund the ARC subscription. Health systems receive structured discharge follow-up and outcomes reporting at zero implementation cost.
ARC builds a prospective, discharge-anchored cohort across multiple health systems, structured for peer-reviewed publication and payer dossier submission from day one.
Claims databases tell you what happened. ARC tells you why, while the patient is still in the window where intervention changes the outcome.
See the DashboardARC gives hospitals structured care coordination infrastructure funded entirely through pharmaceutical partnerships. Reduce 30-day readmissions, support CMS ACCESS Model compliance, and improve patient outcomes. There is no implementation cost or additional headcount required.
Drug, brand, and pharma partner information is not included in the hospital view. All outcomes are attributed to the ARC care coordination program.
ARC gives pharmaceutical companies direct access to de-identified, prospective patient outcome data generated at the point of care, in the post-acute populations that matter most to Medical Affairs, HEOR, Commercial, and Patient Services.
Care coordinators maintain contact with patients throughout the 90-day window. The 30, 60, and 90-day calls are structured data capture points, not the only interactions.
Diagnosis, payer, demographics, and baseline data recorded. Call schedule set.
Coordinators maintain contact throughout. Formal data recorded at 30, 60, and 90-day intervals.
Readmissions, ED visits, and follow-up completion added quarterly from the health system.
Pharma receives the full ARC view. Hospitals receive a de-identified outcomes-only portal.
Cardiovascular benchmark figures across the ARC network. Compared to same-site historical control with propensity score matching.
The barrier shift metric is the one we share publicly. The remaining proprietary metrics are available in the demo.
ARC tracks standard industry metrics every pharma team already knows. On top of those, it captures a set of call-derived data points that do not exist in any claims database, EHR, or published RWE study.
The standard metrics confirm the program works. The proprietary layer explains why patients fail and where the money to fix it should go.
We believe the gap between discharge and recovery is where the healthcare system most fails patients, and where the most important clinical evidence goes uncollected.
Structured post-discharge follow-up should be standard care for every high-risk patient. ARC funds that infrastructure through pharmaceutical partnerships so hospitals do not have to choose between quality and cost.
The healthcare system has enough retrospective claims data. What it lacks is prospective, behavioral, discharge-anchored evidence captured at the moment of the patient decision. ARC generates that data at scale.
ARC is built on the belief that health systems and pharmaceutical companies share a fundamental interest in patient adherence and recovery, and the right infrastructure can make both benefit from the same program.
Schedule a conversation about your therapeutic area, your evidence gaps, and how ARC generates the data your Medical Affairs, HEOR, Commercial, and Patient Services teams need from the point of care.
Book a DemoMedical Affairs, HEOR, RWE, Patient Services, Market Access, and Commercial. The demo is built around your therapeutic area and team priorities.
CMOs, CNOs, and care coordination leaders. See the hospital portal, the discharge protocol, and the outcomes dashboard built for your team.
All data de-identified per HIPAA Safe Harbor. BAAs executed with all health system partners. Enterprise-ready data governance.